ProCE Banner Activity

Case Studies Illustrating the Latest Insights on Treating Polycythemia Vera

Clinical Thought

Read this commentary by 2 experts discussing their approaches to 2 distinct cases of patients with polycythemia vera based on currently available evidence.

Released: February 13, 2023

Expiration: February 12, 2024

Share

Provided by

ProCE Banner

Supporters

Supported by educational grants from

GSK

Incyte Corporation

PharmaEssentia Corp

Disclosure

Raajit Rampal, MD, PhD: consultant: AbbVie, Blueprint, Celgene/Bristol-Myers Squibb, Constellation/MorphoSys, CTI, Galecto, Incyte, Karyopharm, PharmaEssentia, Servier, Sierra Oncology/GlaxoSmithKline, Sumitomo Dainippon Kartos, Zentails; researcher: Constellation Pharmaceuticals, Ryvu, Stemline Therapeutics, Zentalis.

Brady L. Stein, MD, MHS: consultant/advisor/speaker: PharmaEssentia.